SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-17-008006
Filing Date
2017-05-04
Accepted
2017-05-04 16:51:29
Documents
62
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q prog20170331_10q.htm 10-Q 879064
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 15874
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 15917
4 EXHIBIT 32 ex32.htm EX-32 8753
  Complete submission text file 0001437749-17-008006.txt   4781581

Data Files

Seq Description Document Type Size
5 EXHIBIT 101.INS pgnx-20170331.xml EX-101.INS 1120877
6 EXHIBIT 101.SCH pgnx-20170331.xsd EX-101.SCH 45895
7 EXHIBIT 101.CAL pgnx-20170331_cal.xml EX-101.CAL 36002
8 EXHIBIT 101.DEF pgnx-20170331_def.xml EX-101.DEF 284422
9 EXHIBIT 101.LAB pgnx-20170331_lab.xml EX-101.LAB 264550
10 EXHIBIT 101.PRE pgnx-20170331_pre.xml EX-101.PRE 313120
Mailing Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591
Business Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 9147892800
PROGENICS PHARMACEUTICALS INC (Filer) CIK: 0000835887 (see all company filings)

IRS No.: 133379479 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23143 | Film No.: 17814835
SIC: 2834 Pharmaceutical Preparations